vicarioussurgical.com (RBOT) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of Vicarious Surgical Inc (RBOT)

Vicarious Surgical Inc. (RBOT) develops advanced AI-powered VR systems for microsurgery. The long-term debt-to-net assets ratio on the GURU.Markets daily price chart reflects the leverage dynamics, where the 0.85 mark characterizes this parameter. The company currently relies on investments to commercialize its robots while navigating stringent regulatory requirements and intense industry competition.

RBOT vicarioussurgical.com: Long-Term Debt to Equity in the range 07/04/2022 - 03/07/2026

Analytical breakdowns for Vicarious Surgical Inc.

- share price and consensus valuation forecast:
Price Vicarious Surgical Corp|RBOT - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Vicarious Surgical Inc.|RBOT - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Vicarious Surgical|RBOT - Company Book Value|Market Value to Book Value vicarioussurgical.com|RBOT - Company Total Assets
- debt and solvency information:
Total Debt to Capital Vicarious Surgical Inc.|RBOT - Long-Term Debt to Equity|Current Liabilities to Equity Vicarious Surgical Corp|RBOT - Company Aggregate Debts|Debts to Book Value Vicarious Surgical Inc.|RBOT - Company Long-Term Liabilities|Company Short-Term Debts Vicarious Surgical|Intermediate Liquidity Ratio vicarioussurgical.com
- business earnings and investment ratios data:
RBOT - Net Profit
Summary company analysis:RBOT (vicarioussurgical.com)
Core merchandise of Vicarious Surgical Inc

Vicarious Surgical Inc. focuses on the development of surgical robots and preparation for FDA certification. The long-term debt-to-equity dynamics at 0.85 reflect the financing structure of R&D. This metric compares liabilities with maturities exceeding one year against equity, revealing the reliance on borrowed funds. This allows for a distinction between scheduled payments and new share issuances. Investors view this balance as a guarantee of financial stability prior to product commercialization.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Long-Term Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ICU|Long-Term Debt to Equity Ratio iridex.com IRIX|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Long-Term Debt to Capital Beyond Air Inc XAIR|PFSA - Long-Term Debt to Equity|SSKN: Long-Term Debt to Equity|GCTK (GlucoTrack) - Long-Term Debt to Equity Ratio|NanoVibronix Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)